GH Research Plc

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IE000GID8VI0
USD
15.35
1.3 (9.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

221.42 k

Shareholding (Mar 2025)

FII

11.71%

Held by 14 FIIs

DII

74.63%

Held by 13 DIIs

Promoter

5.73%

How big is GH Research Plc?

22-Jun-2025

As of Jun 18, GH Research Plc has a market capitalization of 743.72 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a consolidated net profit of -42.10 million for the latest four quarters. As of Dec 24, the company reported shareholder's funds of 178.95 million and total assets of 188.27 million.

Market Cap: As of Jun 18, GH Research Plc has a market capitalization of 743.72 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, GH Research Plc reported net sales of 0.00 million and a consolidated net profit of -42.10 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 178.95 million and total assets of 188.27 million.

Read More

What does GH Research Plc do?

22-Jun-2025

GH Research Plc is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $11 million and a market cap of $743.72 million. It has no dividend yield, a negative debt equity ratio, and a return on equity of -15.56%.

Overview:<BR>GH Research Plc operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Profit: -11 Million (Quarterly Results - Mar 2025)<BR>- Market cap: USD 743.72 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: NA (Loss Making)<BR>- Industry P/E: NA<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.94<BR>- Return on Equity: -15.56%<BR>- Price to Book: 2.40<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is GH Research Plc technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, GH Research Plc shows a bullish trend overall, supported by daily moving averages and monthly indicators, despite some bearish signals on the weekly charts, and it has significantly outperformed the S&P 500 year-to-date and over the past year.

As of 31 October 2025, the technical trend for GH Research Plc has changed from mildly bullish to bullish. The daily moving averages indicate a bullish stance, while the monthly MACD and KST are also bullish, supporting this positive outlook. However, the weekly MACD and KST are mildly bearish, and the Bollinger Bands show a bearish signal on the weekly timeframe. Overall, the mixed signals suggest a bullish stance but with caution due to the bearish indicators on the weekly charts.<BR><BR>In terms of performance, GH Research has outperformed the S&P 500 year-to-date with a return of 92.86% compared to 16.30%, and over the past year with a return of 65.64% against 19.89%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 838 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.96

stock-summary
Return on Equity

-15.85%

stock-summary
Price to Book

2.76

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-9 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.49%
0%
9.49%
6 Months
27.07%
0%
27.07%
1 Year
82.52%
0%
82.52%
2 Years
139.84%
0%
139.84%
3 Years
24.8%
0%
24.8%
4 Years
-20.3%
0%
-20.3%
5 Years
0%
0%
0.0%

GH Research Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-297.80%
EBIT to Interest (avg)
-20.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.94
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
74.37%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.50
EV to EBIT
-9.40
EV to EBITDA
-9.46
EV to Capital Employed
25.22
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-268.29%
ROE (Latest)
-15.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 7 Schemes (7.93%)

Foreign Institutions

Held by 14 Foreign Institutions (11.71%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 10.58% vs -35.06% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-14.60",
          "val2": "-13.10",
          "chgp": "-11.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.50",
          "val2": "1.60",
          "chgp": "56.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.30",
          "val2": "-10.40",
          "chgp": "10.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -9.55% vs -58.22% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-49.90",
          "val2": "-40.90",
          "chgp": "-22.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.20",
          "val2": "7.10",
          "chgp": "1.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-39.00",
          "val2": "-35.60",
          "chgp": "-9.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-14.60
-13.10
-11.45%
Interest
0.20
0.20
Exceptional Items
2.50
1.60
56.25%
Consolidate Net Profit
-9.30
-10.40
10.58%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 10.58% vs -35.06% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-49.90
-40.90
-22.00%
Interest
0.70
0.70
Exceptional Items
7.20
7.10
1.41%
Consolidate Net Profit
-39.00
-35.60
-9.55%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -9.55% vs -58.22% in Dec 2023

stock-summaryCompany CV
About GH Research Plc stock-summary
stock-summary
GH Research Plc
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available